Phase Ib study of CC-90011 plus etoposide and cisplatin (EP) in patients with first-line extensive-stage (ES) small cell lung cancer (SCLC)

Por: Paz-Ares, L, Juan-Vidal, O, Carcereny, E, Greillier, L, Navarro, A, Bennouna, J, Santoro, A, Berardi, R, Besse, B, Salvagni, S, Gonzalez, H, de Alvaro, J, Parra-Palau, J, Sanchez-Perez, T, Aronchik, I, Filvaroff, E, Lamba, M, Nikolova, Z and Ponce, S

---

Publicada: 1 sep 2020

---

---

Filiaciones:
Paz-Ares, L:
 Univ Complutense, Hosp Univ 12 Octubre, H120 CNIO Lung Canc Unit, Madrid, Spain

 CIBERONC, Madrid, Spain

Juan-Vidal, O:
 Serv Oncol Med, Valencia, Spain

:
 Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol Badalona, Oncol Dept, Badalona, Spain

Greillier, L:
 Aix Marseille Univ, AP HM, Marseille, France

Navarro, A:
 Hosp Univ Vall dHebron, Med Oncol, Barcelona, Spain

Bennouna, J:
 CHU Nantes, Hop Nord Laennec Nantes, Thorac Oncol Unit, Nantes, France

Santoro, A:
 Ist Clin Humanitas Humanitas Canc Ctr, Dept Med Oncol & Hematol, Rozzano, Italy

Berardi, R:
 Univ Politecn Marche, AOU Osped Riuniti, Ancona, Italy

Besse, B:
 Inst Gustave Roussy, Dept Med Oncol, Villejuif, France

Salvagni, S:
 Policlin St Orsolae Malpighi, AOU Bolognae, Oncol Dept, Bologna, Italy

Gonzalez, H:
 Celgene Inst Translat Res Europe, Early Clin Dev, Seville, Spain

de Alvaro, J:
 Celgene Inst Translat Res Europe, Early Clin Dev, Seville, Spain

Parra-Palau, J:
 Celgene Inst Translat Res Europe, Early Clin Dev, Seville, Spain

Sanchez-Perez, T:
 Celgene Inst Translat Res Europe, Early Clin Dev, Seville, Spain

Aronchik, I:
 Bristol Myers Squibb, Epigenet, Princeton, NJ USA

Filvaroff, E:
 Bristol Myers Squibb, Epigenet, Princeton, NJ USA

Lamba, M:
 Bristol Myers Squibb, Epigenet, Princeton, NJ USA

Nikolova, Z:
 Celgene Inst Translat Res Europe, Early Clin Dev, Seville, Spain

Ponce, S:
 Univ Complutense, Hosp Univ 12 Octubre, H120 CNIO Lung Canc Unit, Madrid, Spain

 CIBERONC, Madrid, Spain